The Evolving Landscape of Federal Obesity Treatment The Centers for Medicare & Medicaid Services (CMS) has recently initiated a pivotal shift in how the federal government approaches obesity treatment, marking a significant step toward expanding access to GLP-1 receptor agonists. While Medicare historically restricted coverage for these medications to patients with type 2 diabetes, new…
New Federal Initiative Targets Symptom Management The Trump administration has launched a formal test program authorizing select Medicare patients to receive cannabidiol (CBD) at no cost. This initiative, rolling out across designated regions this year, seeks to evaluate whether the non-psychoactive cannabis compound can effectively manage chronic symptoms in older populations while simultaneously reducing overall…
Senate Confirms Kevin Warsh to Lead Federal Reserve The United States Senate voted on Wednesday to confirm Kevin Warsh as the new Chair of the Federal Reserve, marking a significant transition in the nation’s monetary policy leadership. Warsh, a former Fed governor and veteran of the financial sector, assumes the role during a period of…
